Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Products>This Product

RNAi: siRNA generation kits

Product Image
Product Description

Small Interfering RNA (siRNA)-mediated gene silencing is an exciting and valuable tool for studying gene function. However, most researchers are limited by their ability to test only a handful of chemically synthetic siRNAs due to high cost and lack of design guidance. Dicer siRNA Generation Kit allows cost-effective production of siRNAs targeted against entire gene sequences for efficient gene silencing. Harness the Natural Process. Most researchers purchase 3 to 8 chemically synthesized double-stranded siRNAs for each gene of interest to test whether they can get any strong gene silencing effect. This means synthesizing and processing 6 to 16 RNA oligonucleotides at a relatively high cost. The Dicer siRNA Generation Kits mimic the natural RNA interference process by using the recombinant human dicer enzyme to cleave in vitro transcribed dsRNA into a pool of 20 to 21-bp siRNAs.

Genlantis offers two different types of kits to generate siRNA: the original Dicer siRNA Generation Kits, and the more rapid Turbo Dicer siRNA Generation Kits. Additionally, multiple configurations and component kits of either the original or Turbo Dicer kits are offered to make these kits as convenient and cost effective as possible.

For the utmost in convenience and efficiency, Genlantis also offers one of the most widely-used and effective siRNA delivery reagents on the market, the GeneSilencer™ Transfection Reagent. The GeneSilencer reagent is provided as a prepackaged component of either Dicer siRNA generation kits, or it can be purchased separately in many different sizes and configurations. The GeneSilencer™ siRNA Transfection Reagent ensures efficient delivery of precious siRNA samples, no matter which method is used to produce these siRNAs.

Product RNAi: siRNA generation kits
Company Genlantis
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Genlantis, Inc. 10190 Telesis Court San Diego, CA 92121 1-888-428-0558

Tel: 888-428-0558
Fax: 858-623-9494

Scientific News
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.


Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos